Enlightenment Research, LLC Bio N Tech Se Transaction History

Enlightenment Research, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $744,875 - $1.37 Million	-5,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $584,928 - $978,804	2,700 Added 84.38%	5,900 $274,000
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $658,976 - $1.43 Million	3,200 New	3,200 $874,000
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $498,607 - $1.06 Million	-4,400 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$85.73 - $119.5 $111,449 - $155,350	1,300 Added 41.94%	4,400 $480,000
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $225,400 - $401,574	3,100 New	3,100 $253,000

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.